Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Learn how a newly discovered virus disrupts its host’s nucleus in ways that echo how complex cells may have formed billions ...

A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...

A new study, by Dr. Michael Martynowycz from the Hauptman-Woodward Medical Research Institute (HWI), and researchers at UCLA, and HHMI, reveals how viruses hijack cellular condensates to assemble and ...

Across the world, only a few dozen people appear to carry a genetic glitch that lets them brush off viruses that flatten ...

Viruses rely on hosts to survive. But some viruses are more effective at reproducing than others. Now, new research has shown that the herpes virus, more specifically herpes simplex virus type 1 ...

New findings reveal the presence of replication-competent Oropouche virus in semen, posing fresh questions about sexual transmission risks and public health safety. Research Letter: ...

Single-cell analysis helps uncover how the BK virus replicates, opening the door to new drug targets. BK polyomavirus (BKPyV) is a major cause of kidney transplant failure. Without a complete ...

When people talk about the coronavirus, they sometimes describe this invisible entity as if it has a personality and even a conscience. If you ask a biology or medical student what a virus is, they ...

Ushikuvirus is a newly identified giant virus that infects amoebas, adding to a growing group of oversized viruses that scientists believe may have played an important role in the emergence of complex ...